Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects
NCT01924182 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2018-03-29
Summary
This study compares two different ways to treat pain. The two ways are:
1. continuing to take current pain medication(s) or
2. receiving morphine, a pain medication from a drug pump (a system to deliver drug to your body) that is implanted.
None of the procedures or products used in this study are experimental. The length the study will be about 25 weeks (between 5½ to 6½ months). The purpose of this study is to compare pain and opioid side effects between people who get a drug pump and people who do not get a drug pump that will stay on their current pain medication treatment.
Conditions
Interventions
- DEVICE
-
SynchroMed Infusion System and Intrathecal Morphine Sulfate
Following a successful test of Intrathecal Morphine Sulfate, subjects will undergo surgery to implant the drug pump (SynchroMed Infusion System) and spinal catheter. The pump will deliver morphine directly to the spinal cord for pain control.
- OTHER
-
Conventional Medicine
Subjects will continue to use pain medications as prescribed by their doctor.
Sponsors & Collaborators
-
MedtronicNeuro
lead INDUSTRY
Principal Investigators
-
CONVERT TDD Clinical Research Study Team · MedtronicNeuro
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2015-07-31
- Completion
- 2015-07-31
Countries
- United States
Study Locations
More Related Trials
-
Prometra's Utilization in Mitigating Pain (PUMP)
NCT00817596 ·Status: COMPLETED ·Phase: NA
-
Reduction in Pain Intensity Following IV or Oral Pain-relieving Products
NCT02678416 ·Status: COMPLETED ·Phase: PHASE4
-
Prometra's Utilization in Mitigating Pain II
NCT00866164 ·Status: APPROVED_FOR_MARKETING
-
Comparison of A Single Dose Combination of Methadone and Morphine With Morphine Alone for Treating Post-operative Pain
NCT00142519 ·Status: COMPLETED ·Phase: PHASE2
-
Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration
NCT01709747 ·Status: COMPLETED ·Phase: PHASE3
-
IV Acetaminophen as an Analgesic Adjunct
NCT02621619 ·Status: COMPLETED ·Phase: PHASE4
-
Cessation of Long-term Opioid Therapy in Chronic Pain Patients
NCT02132221 ·Status: TERMINATED ·Phase: NA
-
Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain
NCT02741076 ·Status: TERMINATED ·Phase: PHASE4
-
Prometra Post-Approval Study
NCT01854229 ·Status: COMPLETED ·Phase: NA
-
Endogenous Opioid Response to Injections
NCT06666621 ·Status: RECRUITING ·Phase: PHASE4
-
Using Mobile Devices for Neurofeedback to Reduce Opioid Use in Chronic Pain
NCT04838925 ·Status: UNKNOWN ·Phase: NA
-
Brain Response to Pain Control in People With Chronic Pain
NCT01878019 ·Status: COMPLETED
-
Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia
NCT00004390 ·Status: COMPLETED ·Phase: PHASE3
-
Subjective Observational Study of Patients Using Transdermal Cream Medication And/Or Transdermal Patches With Or Without Oral Non-Narcotic Medications
NCT03768011 ·Status: UNKNOWN
-
Tramadol to Reduce Opioid Withdrawal Symptoms
NCT00142896 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain
NCT00485225 ·Status: COMPLETED ·Phase: PHASE2
-
Intranasal Fentanyl for Pain Management
NCT00882960 ·Status: UNKNOWN ·Phase: PHASE4
-
Cannabis Vs Opioids Pain Management Objective Testing Comparisons
NCT03734731 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Narcotic vs. Non-narcotic Pain Study Protocol
NCT01974609 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients
NCT01100437 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine
NCT04672382 ·Status: COMPLETED ·Phase: NA
-
Adding Nalbuphine for Control of Intrathecal Morphine Pruritus
NCT04589429 ·Status: UNKNOWN ·Phase: PHASE2
-
Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients
NCT01263652 ·Status: WITHDRAWN ·Phase: NA
-
Protocolized vs Discretionary Use of Opioids in Acute Pain
NCT00825370 ·Status: COMPLETED ·Phase: PHASE3
-
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
NCT05506878 ·Status: RECRUITING ·Phase: NA